Novavax, upbeat about progress, loses $45M in 2Q

Novavax Inc., a Gaithersburg biotech company, is pleased with its progress as it shows another quarterly loss. Novavax had a loss of $44.5 million in its second quarter, a lesser loss than the same quarter a year before of $79.4 million. Revenue increased 169 percent from $2.5 million in the same period in 2016 to $6.7 million, ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *